Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Abingworth
Biotech
Gene therapy biotech secures $150M for eye disease candidates
Atsena has raised $150 million to advance its gene therapy designed to reverse or prevent blindness.
Gabrielle Masson
Apr 2, 2025 7:30am
Myricx secures $114M series A to push ADCs into clinic
Jul 8, 2024 1:00am
Abingworth channels $356M into late-stage clinical programs
Oct 30, 2023 10:55am
Nearing clinic, AI-driven Iambic posts $100M round, Nvidia pact
Oct 4, 2023 10:05am
Carlyle's Abingworth buy brings $2 billion for life sciences
Apr 12, 2022 10:00am
Abingworth, Pfizer back $61M gene therapy delivery round
Sep 16, 2021 2:00am
